Aimei Health Technology Co., Ltd. 8-K

What Happened Aimei Health Technology Co., Ltd. announced via Form 8-K that it delivered a notice terminating the Business Combination Agreement with United Hydrogen and certain affiliates on July 7, 2026, effective the same day. The agreement was originally entered into on June 19, 2024 (amended June 6, 2025). As a result, the proposed business combination will not be consummated.

Key Details

• Agreement: Definitive Business Combination Agreement between Aimei Health and United Hydrogen Group Inc. (and related United Hydrogen affiliates), originally dated June 19, 2024 and amended June 6, 2025.
• Termination: Company delivered notice under Section 9.1(b) on July 7, 2026; termination effective July 7, 2026.
• Representative: Aimei Investment Ltd. was named as the post-closing representative for Aimei Health and its shareholders in the agreement.
• Disclosure: Company furnished a press release dated July 8, 2026 (Exhibit 99.1) under Regulation FD, filed with the 8-K.

Why It Matters The termination means the planned merger/acquisition with United Hydrogen will not occur, which directly affects any investor expectations tied to that transaction. Investors should review Aimei Health’s other public filings and the company’s press release for further details on next steps, corporate strategy, funding, or liquidity impacts resulting from the termination.